Inhibitor of apoptosis protein (IAP) antagonists
US11912786B2 · kind B2 · utility
0Cited by
12References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2021 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | Oct 28, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.